Literature DB >> 7991433

Iron supplementation in children after cardiopulmonary bypass for surgical repair of congenital heart disease.

C Aufricht1, M Ties, M Wimmer, F Haschke, B Pietschnig, K Herkner.   

Abstract

A controlled study was carried out to evaluate the effects of postoperative iron therapy on iron status in anemic children after cardiopulmonary bypass. The patients were 8 boys and 9 girls (mean age 6.5 years) who underwent elective closure of atrial septal defect, secundum type. On postoperative day 9, patients were randomly assigned to either iron supplementation with iron sulfate 5 mg/kg until day 56 or to a control group. Hemoglobin, reticulocytes, transferrin saturation, free erythrocyte protoporphyrin, and ferritin were measured, the final outcome measure being postoperative iron status on day 56. The treatment group showed higher transferrin saturations (33.5% versus 18.0%), smaller decreases in ferritin level (+3.0 versus--13.7 ng/ml), and a lower incidence of depleted iron stores (0/8 versus 5/9) than the control group (all data: P < 0.05). Anemic children after cardiopulmonary bypass for surgical repair of congenital heart disease thus benefit from iron supplementation within the first postoperative weeks.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7991433     DOI: 10.1007/BF00800670

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  11 in total

1.  Rate of blood regeneration after blood loss.

Authors:  D H COLEMAN; A R STEVENS; H T DODGE; C A FINCH
Journal:  AMA Arch Intern Med       Date:  1953-09

Review 2.  The role of recombinant human erythropoietin in homologous transfusion avoidance.

Authors:  J T Sobota
Journal:  Contrib Nephrol       Date:  1991       Impact factor: 1.580

Review 3.  Erythropoiesis and inflammation.

Authors:  G Birgegård
Journal:  Contrib Nephrol       Date:  1989       Impact factor: 1.580

4.  Response of various indices of iron status to acute iron depletion produced in menstruating women by low iron intake and phlebotomy.

Authors:  D B Milne; S K Gallagher; F H Nielsen
Journal:  Clin Chem       Date:  1990-03       Impact factor: 8.327

5.  Perioperative recombinant human erythropoietin.

Authors:  E A Levine; S A Gould; A L Rosen; L R Sehgal; J C Egrie; H L Sehgal; H D Levine; G S Moss
Journal:  Surgery       Date:  1989-08       Impact factor: 3.982

6.  Estimating allowable hemodilution.

Authors:  D L Bourke; T C Smith
Journal:  Anesthesiology       Date:  1974-12       Impact factor: 7.892

7.  Transfusion-associated fatalities: review of Bureau of Biologics reports 1976-1978.

Authors:  C L Honig; J R Bove
Journal:  Transfusion       Date:  1980 Nov-Dec       Impact factor: 3.157

Review 8.  Erythropoiesis, erythropoietin, and iron.

Authors:  C A Finch
Journal:  Blood       Date:  1982-12       Impact factor: 22.113

9.  Transfusion-associated hepatitis and AIDS. What is the risk?

Authors:  J R Bove
Journal:  N Engl J Med       Date:  1987-07-23       Impact factor: 91.245

10.  Fever, leucocytosis and infection after open heart surgery. A log-linear regression analysis of 115 cases.

Authors:  J Miholic; H Hiertz; M Hudec; A Laczkovics; E Domanig
Journal:  Thorac Cardiovasc Surg       Date:  1984-02       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.